DK0869772T3 - Bioadhæsiv fast doseringsform - Google Patents

Bioadhæsiv fast doseringsform

Info

Publication number
DK0869772T3
DK0869772T3 DK96944692T DK96944692T DK0869772T3 DK 0869772 T3 DK0869772 T3 DK 0869772T3 DK 96944692 T DK96944692 T DK 96944692T DK 96944692 T DK96944692 T DK 96944692T DK 0869772 T3 DK0869772 T3 DK 0869772T3
Authority
DK
Denmark
Prior art keywords
solid dosage
dosage form
dosage forms
bioadhesive
bioadhesive solid
Prior art date
Application number
DK96944692T
Other languages
Danish (da)
English (en)
Inventor
Paul Marie Victor Gilis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK0869772T3 publication Critical patent/DK0869772T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96944692T 1995-12-27 1996-12-20 Bioadhæsiv fast doseringsform DK0869772T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95203649 1995-12-27
PCT/EP1996/005884 WO1997024109A1 (en) 1995-12-27 1996-12-20 Bioadhesive solid dosage form

Publications (1)

Publication Number Publication Date
DK0869772T3 true DK0869772T3 (da) 2002-01-21

Family

ID=8221021

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96944692T DK0869772T3 (da) 1995-12-27 1996-12-20 Bioadhæsiv fast doseringsform

Country Status (27)

Country Link
US (1) US6303147B1 (pt)
EP (1) EP0869772B1 (pt)
JP (1) JP4317264B2 (pt)
KR (1) KR100459029B1 (pt)
CN (1) CN1146401C (pt)
AT (1) ATE206304T1 (pt)
AU (1) AU713849B2 (pt)
BR (1) BR9612291A (pt)
CA (1) CA2232152C (pt)
CY (1) CY2269B1 (pt)
CZ (1) CZ298690B6 (pt)
DE (1) DE69615704T2 (pt)
DK (1) DK0869772T3 (pt)
EA (1) EA000818B1 (pt)
ES (1) ES2164940T3 (pt)
HK (1) HK1015680A1 (pt)
HU (1) HU228350B1 (pt)
IL (1) IL123636A (pt)
NO (1) NO320015B1 (pt)
NZ (1) NZ325844A (pt)
PL (1) PL186278B1 (pt)
PT (1) PT869772E (pt)
SI (1) SI0869772T1 (pt)
SK (1) SK283370B6 (pt)
TR (1) TR199800894T2 (pt)
WO (1) WO1997024109A1 (pt)
ZA (1) ZA9610886B (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080213378A1 (en) * 1998-10-01 2008-09-04 Elan Pharma International, Ltd. Nanoparticulate statin formulations and novel statin combinations
EP2266542A3 (en) * 1998-10-01 2013-07-31 Elan Pharma International Limited Controlled release nanoparticulate compositions
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
US6428814B1 (en) * 1999-10-08 2002-08-06 Elan Pharma International Ltd. Bioadhesive nanoparticulate compositions having cationic surface stabilizers
ATE313319T1 (de) 1999-03-31 2006-01-15 Janssen Pharmaceutica Nv Vorgelatinierte stärke in einer formulierung mit gesteuerter freigabe
US7503493B2 (en) * 1999-10-25 2009-03-17 Silverbrook Research Pty Ltd Method and system for digitizing freehand graphics with user-selected properties
US20040156872A1 (en) * 2000-05-18 2004-08-12 Elan Pharma International Ltd. Novel nimesulide compositions
US7198795B2 (en) 2000-09-21 2007-04-03 Elan Pharma International Ltd. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
US8980334B2 (en) 2001-02-28 2015-03-17 Axiomedic Ltd. Double-layered absorbable solid compositions for the topical treatment of oral mucosal disorders
EP2324821A1 (en) * 2001-02-28 2011-05-25 Axiomedic Ltd. Oral care compositions
FR2827517B1 (fr) * 2001-07-23 2003-10-24 Bioalliance Pharma Systemes therapeutiques bioadhesifs a liberation prolongee
US20030124196A1 (en) * 2001-08-22 2003-07-03 Susan Weinbach Pulsatile release compositions and methods for enhanced intestinal drug absorption
US20030083286A1 (en) * 2001-08-22 2003-05-01 Ching-Leou Teng Bioadhesive compositions and methods for enhanced intestinal drug absorption
US7709026B2 (en) * 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
US7846478B2 (en) 2002-01-31 2010-12-07 Henkel Ag & Co. Kgaa Bioadhesive composition
DK1471887T3 (da) 2002-02-04 2010-06-07 Elan Pharma Int Ltd Nanopartikelkompositioner der har lysozym som overfladestabiliseringsmiddel
AU2003261167A1 (en) * 2002-07-16 2004-02-02 Elan Pharma International, Ltd Liquid dosage compositions of stable nanoparticulate active agents
MY142204A (en) 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
WO2005032554A1 (en) 2003-10-03 2005-04-14 Astron Research Pvt. Ltd A novel transmucosal delivery system
EP1734931A2 (en) * 2004-03-24 2006-12-27 Actavis Group Formulations of ramipril
US9925139B2 (en) * 2004-04-22 2018-03-27 Acucort Ab Pharmaceutical compositions for acute glucocorticoid therapy
TWI338583B (en) * 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
CN101843597A (zh) 2004-08-13 2010-09-29 贝林格尔·英格海姆国际有限公司 包含普拉克索或其可药用盐的延长释放小球制剂、其制备方法及其用途
US20070048369A1 (en) * 2005-08-26 2007-03-01 National Starch And Chemical Investment Holding Corporation Mucosal delivery tablet
GB0518129D0 (en) * 2005-09-06 2005-10-12 Arrow Int Ltd Ramipril formulation
US20070098782A1 (en) * 2005-10-28 2007-05-03 Selamine Limited Ramipril Formulation
GB2431579A (en) * 2005-10-28 2007-05-02 Arrow Int Ltd Ramipril formulations
US8349120B2 (en) * 2006-03-07 2013-01-08 Ora Health Corporation Multi-layer patch made on a sheet and enclosed in a blister
EP1837020A1 (en) 2006-03-24 2007-09-26 Bioalliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles
US20070248655A1 (en) * 2006-04-21 2007-10-25 Haley Jeffrey T Lenticular shaped protective mouth sore discs
EP2037895A4 (en) * 2006-05-23 2009-12-02 Orahealth Corp XYLITOL-PASTILLAS AND METHOD OF USE
US20070293587A1 (en) * 2006-05-23 2007-12-20 Haley Jeffrey T Combating sinus, throat, and blood infections with xylitol delivered in the mouth
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
RU2444364C2 (ru) * 2006-07-12 2012-03-10 Контроллд Терапьютикс (Скотлэнд) Лтд. Полимер для доставки лекарств с гидрохлоридной солью клиндамицина
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
EP2942053A1 (en) 2007-07-06 2015-11-11 Lupin Limited Pharmaceutical compositions for gastrointestinal drug delivery
US20120027855A1 (en) 2007-07-06 2012-02-02 Lupin Limited Pharmaceutical compositions for gastrointestinal drug delivery
US8974825B2 (en) * 2007-07-06 2015-03-10 Lupin Limited Pharmaceutical compositions for gastrointestinal drug delivery
EP2163240A1 (en) * 2008-09-12 2010-03-17 Universita' Degli Studi Di Genova A method for the production of bioadhesive compact matrices
KR20140114269A (ko) 2010-12-20 2014-09-26 이 아이 듀폰 디 네모아 앤드 캄파니 표적화된 과가수분해효소
JO3256B1 (ar) * 2013-03-06 2018-09-16 Novartis Ag صياغات من مركبات عضوية
CN105193768A (zh) * 2015-08-27 2015-12-30 武汉武药科技有限公司 一种曲安奈德口腔粘贴片及其制备工艺
RS64644B9 (sr) * 2016-07-15 2024-02-29 H2 Water Tech Ltd Kompozicije za proizvodnju vode obogaćene vodonikom

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3554764A (en) * 1967-12-21 1971-01-12 Gen Foods Corp Freeze-thaw resistant flour and starch thickener blend
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
EP0451433B1 (en) * 1990-04-12 1996-10-23 Janssen Pharmaceutica N.V. Composition of a bioadhesive sustained delivery carrier for drug administration
US5330761A (en) * 1993-01-29 1994-07-19 Edward Mendell Co. Inc. Bioadhesive tablet for non-systemic use products
US5662933A (en) * 1993-09-09 1997-09-02 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
US5370878A (en) 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
TW355683B (en) 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US5656283A (en) 1995-06-08 1997-08-12 Ortho Pharmaceutical Corporation In-situ lyophilization of vaginal suppository in unit dose applicator and resultant product

Also Published As

Publication number Publication date
TR199800894T2 (xx) 1998-08-21
CZ298690B6 (cs) 2007-12-27
SI0869772T1 (en) 2002-04-30
CZ199298A3 (cs) 1998-09-16
HU228350B1 (hu) 2013-03-28
AU1308597A (en) 1997-07-28
KR100459029B1 (ko) 2006-03-27
HK1015680A1 (en) 1999-10-22
JP2000502691A (ja) 2000-03-07
DE69615704T2 (de) 2002-07-11
EA199800350A1 (ru) 1998-10-29
NZ325844A (en) 1999-06-29
NO320015B1 (no) 2005-10-10
CY2269B1 (en) 2003-07-04
WO1997024109A1 (en) 1997-07-10
CN1200667A (zh) 1998-12-02
HUP9802913A3 (en) 2000-06-28
ZA9610886B (en) 1998-06-23
CA2232152A1 (en) 1997-07-10
BR9612291A (pt) 1999-07-13
ES2164940T3 (es) 2002-03-01
HUP9802913A2 (hu) 1999-06-28
DE69615704D1 (de) 2001-11-08
ATE206304T1 (de) 2001-10-15
US6303147B1 (en) 2001-10-16
IL123636A0 (en) 1998-10-30
KR19990067112A (ko) 1999-08-16
PT869772E (pt) 2002-03-28
EA000818B1 (ru) 2000-04-24
SK88798A3 (en) 1998-11-04
PL186278B1 (pl) 2003-12-31
SK283370B6 (sk) 2003-06-03
NO981027D0 (no) 1998-03-09
AU713849B2 (en) 1999-12-09
EP0869772B1 (en) 2001-10-04
NO981027L (no) 1998-06-15
CA2232152C (en) 2007-02-06
PL326196A1 (en) 1998-08-31
CN1146401C (zh) 2004-04-21
IL123636A (en) 2001-04-30
JP4317264B2 (ja) 2009-08-19
EP0869772A1 (en) 1998-10-14

Similar Documents

Publication Publication Date Title
DK0869772T3 (da) Bioadhæsiv fast doseringsform
ES534096A0 (es) Procedimiento de obtencion de tabletas farmaceuticas administrables por via oral
KR950007841A (ko) 트라마돌 염을 함유하는 서방성 약물 제제
BG105857A (en) Pregelatinized starch in a controlled release formulation
UA41346C2 (uk) Фармацевтична композиція, яка містить флуоксетин або його сіль, таблетка на її основі, спосіб виробництва таблетки, яка диспергується
KR890001526A (ko) 경구용 서방성 아세트 아미노펜 제형 및 이의 제조방법
CA2385890A1 (en) Controlled release compositions comprising nimesulide
CA2445519A1 (en) Method for manufacturing a low dose pharmaceutical composition
CA2214026A1 (en) Pharmaceutical compositions comprising monoamine oxidase b inhibitors
FR2698788B1 (fr) Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
TNSN04048A1 (en) Dosage regimen and pharmaceutical composition for emergency contraception
PT975348E (pt) Composicoes de tibolona estabilizadas
CA2417935A1 (en) Anti-inflammatory medicament
AP1485A (en) Orally administered controlled delivery system for once daily administration of ciprofloxacin.
CA2348474A1 (en) Pharmaceutically active composition and dispensing device
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
HUP9901208A2 (hu) (R)-5-Bróm-n-(1-etil-4-metil-hexahidro-1H-1,4-diazepin-6-il)-2-metoxi-6-(metil-amino)-3-piridin-karboxamid, eljárás előállítására és ezt a vegyületet tartalmazó gyógyászati készítmény
RU94046069A (ru) Фармацевтическая композиция, содержащая алкилсульфонамид-агонист 5нт*001, для ректального введения, способ получения фармацевтической композиции, способ лечения состояний, связанных с головной болью
TH59375A3 (th) สูตรผสมทางเภสัช ที่ซึ่งการปลดปล่อยออกได้ถูกควบคุม